MCL1 and pancreatic neoplasm: Although chemotherapeutic resistance in pancreatic cancer is a serious problem and occurs through various molecular pathways [33], our data showed that FBXW7 and its substrate MCL1 are important factors involved in chemotherapeutic resistance and are expected to be candidate therapeutic targets for overcoming therapeutic resistance.